Hepatitis C screening study launched in France:
This article was originally published in Clinica
The French Association for the Study of Hepatitis C Screening (ADHEC) has selected three sites around Lyon, Creteil and Besancon to carry out a study into the different strategies for hepatitis C screening. The study is intended to determine the exact levels of hepatitis C in the population and identify the principle risk factors. Until now, only 20% of people affected by the virus have been identified, which represents 1% of the French population, says Le Quotidien du Medecin.
You may also be interested in...
Teva plans to begin appeal proceedings, the firm has told Generics Bulletin, after being fined €60.5m ($72m) by the European Commission over an historic “pay-for-delay” arrangement covering subsidiary firm Cephalon’s Provigil (modafinil).
SK set for Korean trial with vaccine, as Biological E begins human trials of Baylor vaccine. Meanwhile, DongWha gets a Phase II nod for potential drug, and Celltrion progesses with Phase II regdanvimab trial.
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.